These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11170867

  • 21. p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
    Yang CT, You L, Uematsu K, Yeh CC, McCormick F, Jablons DM.
    Cancer Res; 2001 Aug 15; 61(16):5959-63. PubMed ID: 11507034
    [Abstract] [Full Text] [Related]

  • 22. Development of a novel recombinant adenovirus containing gfp-zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cells.
    Hu B, Joshua MN, Dong C, Qi Y.
    J Virol Methods; 2004 May 15; 117(2):129-36. PubMed ID: 15041209
    [Abstract] [Full Text] [Related]

  • 23. Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription.
    Sieber T, Dobner T.
    J Virol; 2007 Jan 15; 81(1):95-105. PubMed ID: 17050591
    [Abstract] [Full Text] [Related]

  • 24. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells.
    Steegenga WT, Riteco N, Bos JL.
    Oncogene; 1999 Sep 09; 18(36):5032-43. PubMed ID: 10490840
    [Abstract] [Full Text] [Related]

  • 25. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
    Zhao J, Wang H, Wei L, Habib NA, Lu X, Wu M, Guo Y.
    Cancer Gene Ther; 2001 May 09; 8(5):333-41. PubMed ID: 11477453
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function.
    Hsieh JL, Wu CL, Lee CH, Shiau AL.
    Clin Cancer Res; 2003 Jan 09; 9(1):338-45. PubMed ID: 12538486
    [Abstract] [Full Text] [Related]

  • 27. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells.
    Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, zur Hausen H.
    J Virol; 1998 Dec 09; 72(12):9470-8. PubMed ID: 9811680
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J, Cho JY, Kim JH, Jung KC, Yun CO.
    Cancer Gene Ther; 2002 Sep 09; 9(9):725-36. PubMed ID: 12189522
    [Abstract] [Full Text] [Related]

  • 29. [Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines].
    Zhao J, Lü Y, Guo Y.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 09; 23(5):366-8. PubMed ID: 11810762
    [Abstract] [Full Text] [Related]

  • 30. Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.
    Hann B, Balmain A.
    J Virol; 2003 Nov 09; 77(21):11588-95. PubMed ID: 14557644
    [Abstract] [Full Text] [Related]

  • 31. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
    Zheng X, Rao XM, Snodgrass CL, McMasters KM, Zhou HS.
    Cancer Gene Ther; 2006 Jun 09; 13(6):572-83. PubMed ID: 16341141
    [Abstract] [Full Text] [Related]

  • 32. Interaction of p53 with the adenovirus E1B-55 kDa protein.
    Roth J, Dobbelstein M.
    Methods Mol Biol; 2003 Jun 09; 234():135-49. PubMed ID: 12824530
    [Abstract] [Full Text] [Related]

  • 33. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
    Kirn D.
    Gene Ther; 2001 Jan 09; 8(2):89-98. PubMed ID: 11313778
    [Abstract] [Full Text] [Related]

  • 34. Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.
    Sauthoff H, Pipiya T, Chen S, Heitner S, Cheng J, Huang YQ, Rom WN, Hay JG.
    Cancer Gene Ther; 2006 Jul 09; 13(7):686-95. PubMed ID: 16470212
    [Abstract] [Full Text] [Related]

  • 35. Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy.
    O'Shea CC, Soria C, Bagus B, McCormick F.
    Cancer Cell; 2005 Jul 09; 8(1):61-74. PubMed ID: 16023599
    [Abstract] [Full Text] [Related]

  • 36. Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.
    Thorne SH, Brooks G, Lee YL, Au T, Eng LF, Reid T.
    J Virol; 2005 Jan 09; 79(1):581-91. PubMed ID: 15596850
    [Abstract] [Full Text] [Related]

  • 37. Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription.
    Härtl B, Zeller T, Blanchette P, Kremmer E, Dobner T.
    Oncogene; 2008 Jun 12; 27(26):3673-84. PubMed ID: 18212738
    [Abstract] [Full Text] [Related]

  • 38. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
    Qian Q, Sham J, Che X, Xu J, Xue H, Cui Z, Zhu B, Wu M.
    Chin Med J (Engl); 2002 Aug 12; 115(8):1213-7. PubMed ID: 12215295
    [Abstract] [Full Text] [Related]

  • 39. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis.
    Harada N, Maniwa Y, Yoshimura M, Nagata M, Hamada H, Yokono K, Okita Y.
    Oncol Rep; 2005 Nov 12; 14(5):1155-63. PubMed ID: 16211279
    [Abstract] [Full Text] [Related]

  • 40. An early function of the adenoviral E1B 55 kDa protein is required for the nuclear relocalization of the cellular p53 protein in adenovirus-infected normal human cells.
    Cardoso FM, Kato SE, Huang W, Flint SJ, Gonzalez RA.
    Virology; 2008 Sep 01; 378(2):339-46. PubMed ID: 18632130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.